Document is current
Any future updates will be listed below
-
Authors
Yi, Na
Wang, Han-rui
Zhu, Yu-ping
Xiao, Tao
Lin, Qin
Liu, Huan
Meng, Yi-lei
Sun, Yi-zhuo
Lin, Fang
Hu, Sang-yu
Cao, Hua-ming
Zhang, Jun-fang
Peng, Lu-ying
Li, Li
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82070270, 32071109, 82470408)
the National Key Research and Development Program (2022YFE0100400)
the Shanghai Committee of Science and Technology (22ZR1463800)
Li Li is a fellow at the Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University. (Li Li is a fellow at the Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University.)
- License Information
-
More Information
Article History
Received: 15 October 2024
Accepted: 6 March 2025
First Online: 18 March 2025
Declarations
:
: Human ESC line WA07 (H7) used in this study was kindly donated by Prof. Qing Jing from Shanghai Institutes for Biological Sciences Chinese Academy of Sciences. Their hESC line (H7) was obtained from WiCell (Madison, WI) (WA07). The use of the hESC line was approved by the Ethical Committee of Changhai Hospital, and the original publication on the cell line by the source lab is cited in reference 36 (PMID: 28971953).
: All authors confirm their consent for publication.
: The authors declare that artificial intelligence is not used in this study.
: All authors certify that they have no conflicts of interest.
